RAD51 and cancer: Combining the PtenR173C mutation in mouse models carrying additional cancer drivers (such as PIK3CA mutation) or defects in DNA repair genes (such as Brca or Rad51) could provide evidence for this speculation, but such experiments are outside the scope of the current study.